Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2024-09-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押及解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge and release of shares by the controlling shareholders of the company. It details the number of shares pledged, the dates, the pledgees, and the cumulative pledge status. There is no financial performance data, no discussion of financial results, no management commentary, and no mention of any report publication. The document is a regulatory announcement about share pledges, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA) because it is about share pledges, not new share issuance or capital changes. The document length is short and it is a straightforward announcement of share pledge status.
2024-09-10 Chinese
关于控股股东部分股份质押及解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge and release of shares by the controlling shareholders of the company. It details the number of shares pledged, released, and the related percentages of ownership. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement about share pledging activities by major shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a full report or earnings release.
2024-09-06 Chinese
2024年半年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of a profit distribution (dividend) plan for the company's 2024 half-year period. It details the dividend amount per share, the approval by the shareholders' meeting, the record date, and the payment date. It does not contain financial statements or detailed financial analysis but focuses on dividend distribution specifics. This matches the definition of a Notice of Dividend Amount (DIV). The document length is short (1895 characters), and it is not merely announcing the publication of a report but providing the dividend distribution details themselves.
2024-09-06 Chinese
北京市中伦（深圳）律师事务所关于海思科医药集团股份有限公司2024年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, qualifications, and voting results of the 2024 first extraordinary general meeting (临时股东大会) of shareholders of a company. It details the legality and validity of the meeting's call, attendance, voting procedures, and results. It does not contain financial statements or management discussion but focuses on the legal aspects of the shareholder meeting and the voting outcomes. This type of document is typically classified as Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholder meeting.
2024-09-05 Chinese
关于2024年限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告
Regulatory Filings Classification · 95% confidence The document is a self-inspection report regarding insider trading and stock transactions by insiders related to a 2024 restricted stock incentive plan. It details the investigation and findings about stock trades by insiders during a specific period, confirming no insider trading occurred. The document is a regulatory announcement about compliance and insider trading checks, not a financial report, earnings release, or management report. It fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure without financial statements or report publication.
2024-09-05 Chinese
2024年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2024 first extraordinary general meeting (临时股东大会) of the company 海思科医药集团股份有限公司. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and voting procedures. The content focuses on the official results of shareholder votes at this general meeting. The document length is 3322 characters, which is relatively short but contains detailed voting results rather than just a notice of report publication. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)', which covers official results from shareholder votes at any general meeting. Therefore, the correct classification is DVA.
2024-09-05 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.